Prolia, generic denosumab, is a new treatment for prevention of osteoporosis and bone related disease. It is a monoclonal antibody to RANKL and acts by preventing it from activating its target receptors. Since RANKL promotes cells to grow that digest... (Continue reading)
Apixaban is a new medication being developed for a variety of uses involving blood coagulation. Blood clotting is a serious problem that is extremely common and the existing anticoagulants have significant limitations. Studies so far have shown that Apixaban is... (Continue reading)
Olaparib is a member of the poly-ADP ribose polymerase (PARP) inhibitors and may work as a treatment for certain types of breast, ovarian and prostate cancer. PARP is involved in repairing DNA damage. By inhibiting PARP, rapidly growing cells such... (Continue reading)
Bydureon is a once weekly form of Byetta, an increasingly popular diabetes medication. It has a variety of effects that make it a useful treatment for diabetes. Most importantly, it helps lower blood sugar and has tended to help... (Continue reading)